Cargando…

Gastrointestinal symptom severity and progression in systemic sclerosis

OBJECTIVES: To evaluate the severity and evolution of patient-reported gastrointestinal tract (GIT) symptoms in systemic sclerosis (SSc) patients, assess predictive factors for progression and determine the impact of standard of care treatment. METHODS: SSc patients from the Leiden and Oslo cohorts...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Leeuwen, Nina M, Boonstra, Maaike, Fretheim, Håvard, Brunborg, Cathrine, Midtvedt, Øyvind, Garen, Torhild, Molberg, Øyvind, Huizinga, Tom W J, de Vries-Bouwstra, Jeska K, Hoffman-Vold, Anna-Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789747/ https://www.ncbi.nlm.nih.gov/pubmed/35238377 http://dx.doi.org/10.1093/rheumatology/keac118

Ejemplares similares

Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
por: Fretheim, Håvard, et al.
Publicado: (2020)

Serum markers of cardiac complications in a systemic sclerosis cohort
por: Tennøe, Anders H., et al.
Publicado: (2022)

Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
por: Tennøe, Anders H., et al.
Publicado: (2019)

Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
por: Didriksen, Henriette, et al.
Publicado: (2022)

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
por: Fretheim, Håvard, et al.
Publicado: (2020)

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
por: Strahm, Noemi, et al.
Publicado: (2023)

Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study
por: van Leeuwen, Nina M., et al.
Publicado: (2020)

Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
por: Reiseter, Silje, et al.
Publicado: (2015)

Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
por: Vikse, Jens, et al.
Publicado: (2023)

Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide
por: Ciaffi, Jacopo, et al.
Publicado: (2022)

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis
por: van Leeuwen, Nina M., et al.
Publicado: (2021)

Augmented concentrations of CX(3)CL1 are associated with interstitial lung disease in systemic sclerosis
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2018)

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
por: Wortel, Corrie M, et al.
Publicado: (2023)

Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature
por: van Leeuwen, Nina M., et al.
Publicado: (2021)

Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study
por: Andersson, Helena, et al.
Publicado: (2017)

Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants
por: van Leeuwen, Nina M, et al.
Publicado: (2021)

Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
por: Volkmann, Elizabeth R, et al.
Publicado: (2017)

Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2020)

Rituximab in early systemic sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2017)

Disease progression in systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2021)

Pulmonary veno-occlusive disease in a patient with recently diagnosed systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2019)

A prediction model for progressive disease in systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2015)

New risk model is able to identify patients with a low risk of progression in systemic sclerosis
por: van Leeuwen, Nina Marijn, et al.
Publicado: (2021)

Systemic sclerosis in the time of COVID-19
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2022)

Whole body insulin sensitivity is increased in systemic sclerosis
por: Ciaffi, Jacopo, et al.
Publicado: (2023)

Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
por: Gegenava, Tea, et al.
Publicado: (2023)

Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort
por: Liem, Sophie I E, et al.
Publicado: (2023)

TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study
por: Gudbrandsson, Birgir, et al.
Publicado: (2017)

Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2016)

The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis
por: Liem, Sophie IE, et al.
Publicado: (2023)

Anti-carbamylated protein antibodies in systemic sclerosis
por: Liem, Sophie I. E., et al.
Publicado: (2023)

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
por: Takata, Miki, et al.
Publicado: (2019)

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies
por: Liem, Sophie I E, et al.
Publicado: (2023)

The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
por: Liem, Sophie I E, et al.
Publicado: (2022)

The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review
por: Liem, Sophie I E, et al.
Publicado: (2019)

Requirements for systemic sclerosis expert centres in the Netherlands: A Delphi consensus study
por: Spierings, Julia, et al.
Publicado: (2020)

Long-Term Outcome in Systemic Lupus Erythematosus; Knowledge from Population-Based Cohorts
por: Reppe Moe, Sigrid, et al.
Publicado: (2021)

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients
por: Chadli, Loubna, et al.
Publicado: (2019)

Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report
por: Myhre, Hans-Arne, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_g1ad31bonohrtmohnufa87ebog